Showing results (1-10 of 104) with videos related to
Sort By:
Pageof 11
Cancer Biology & Therapy|March 23, 2006
DNA damage response: determining the fate of phosphorylated histone H2AXJonathan Rios-Doria, Alyson Fay, Aneliya Velkova, et al.Anti-Cancer Agents in Medicinal Chemistry|June 13, 2009
Can the status of the breast and ovarian cancer susceptibility gene 1 product (BRCA1) predict response to taxane-based cancer therapy?J Thomas De Ligio, Aneliya Velkova, Diego A R Zorio, et al.Cell Cycle (Georgetown, Tex.)|March 23, 2010
Identification of Filamin A as a BRCA1-interacting protein required for efficient DNA repairAneliya Velkova, Marcelo A Carvalho, Joseph O Johnson, et al.Cancer Biology & Therapy|March 24, 2009
Ectopic expression of histone H2AX mutants reveals a role for its post-translational modificationsJonathan Rios-Doria, Aneliya Velkova, Virna Dapic, et al.Plos One|May 22, 2014
Probing structure-function relationships in missense variants in the carboxy-terminal region of BRCA1Renato S Carvalho, Renata B V Abreu, Aneliya Velkova, et al.Trends in Genetics : TIG|June 13, 2003
BRCA1: the enigma of tissue-specific tumor developmentAlvaro N A MonteiroZeitschrift Fur Naturforschung. C, Journal of Biosciences|November 13, 2008
Comparison of the global genomic and transcription-coupled repair rates of different lesions in human cellsBoyko Atanassov, Aneliya Velkova, Emil Mladenov, et al.Biochemical Pharmacology|June 1, 2010
Fine tuning chemotherapy to match BRCA1 statusMelissa Price, Alvaro N A MonteiroCritical Reviews in Eukaryotic Gene Expression|November 1, 2006
Functional implications of BRCA1 for early detection, prevention, and treatment of breast cancerVirna Dapić, Alvaro N A MonteiroCancer Letters|July 30, 2005
BRCA1 in breast and ovarian cancer predispositionBlase Billack, Alvaro N A MonteiroPageof 11